PL1638591T3 - Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych - Google Patents
Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnychInfo
- Publication number
- PL1638591T3 PL1638591T3 PL04735259T PL04735259T PL1638591T3 PL 1638591 T3 PL1638591 T3 PL 1638591T3 PL 04735259 T PL04735259 T PL 04735259T PL 04735259 T PL04735259 T PL 04735259T PL 1638591 T3 PL1638591 T3 PL 1638591T3
- Authority
- PL
- Poland
- Prior art keywords
- agonists
- reduction
- blood vessel
- class iii
- vessel formation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0312292A GB0312292D0 (en) | 2003-05-29 | 2003-05-29 | Treatment of blood vessels |
GB0400547A GB0400547D0 (en) | 2004-01-12 | 2004-01-12 | Treatment of blood vessels |
PCT/GB2004/002269 WO2004105784A1 (en) | 2003-05-29 | 2004-05-28 | Class iii slrp agonists for the reduction of blood vessel formation |
EP04735259A EP1638591B1 (en) | 2003-05-29 | 2004-05-28 | Class iii slrp agonists for the reduction of blood vessel formation |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1638591T3 true PL1638591T3 (pl) | 2013-10-31 |
Family
ID=33492244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04735259T PL1638591T3 (pl) | 2003-05-29 | 2004-05-28 | Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych |
Country Status (8)
Country | Link |
---|---|
US (2) | US7358224B2 (pl) |
EP (1) | EP1638591B1 (pl) |
JP (1) | JP4808623B2 (pl) |
DK (1) | DK1638591T3 (pl) |
ES (1) | ES2408656T3 (pl) |
PL (1) | PL1638591T3 (pl) |
PT (1) | PT1638591E (pl) |
WO (1) | WO2004105784A1 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1638591T3 (pl) * | 2003-05-29 | 2013-10-31 | Univ Manchester | Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych |
GB0423273D0 (en) * | 2004-10-20 | 2004-11-24 | Univ Manchester | Treatment of cancer |
GB0724832D0 (en) * | 2007-12-20 | 2008-01-30 | Univ Manchester | Proteins and nucleic acids |
CA2769243C (en) | 2009-07-27 | 2017-08-22 | F. Hoffmann-La Roche Ag | Use of mimecan in the assessment of heart failure |
WO2011069046A1 (en) * | 2009-12-04 | 2011-06-09 | Euclid Systems Corporation | Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
CN102188694B (zh) * | 2010-03-11 | 2015-05-06 | 上海交通大学医学院附属瑞金医院 | 骨生成诱导因子的用途 |
EP3115784A1 (en) * | 2015-07-10 | 2017-01-11 | Koss, Michael Janusz | Polypeptide marker for analysis, diagnosis and therapy of eye-related diseases |
US20180369325A1 (en) * | 2015-11-19 | 2018-12-27 | Garvan Institute Of Medical Research | Compounds and methods for treating metabolic disorders |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827702A (en) * | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
DE4445630A1 (de) | 1994-12-21 | 1996-06-27 | Forssmann Wolf Georg | Humane zirkulierende Peptidfragmente 20-92 und 23-74 des Precursor des Osteoinduktiven Faktors kurz: OIF-20-92 und OIF 23-74 |
EP0859636A4 (en) | 1995-10-23 | 2002-05-02 | Hyal Pharmaceutical Australia | HYALURONIC ACID USED AS A DNA CARRIER FOR GENE THERAPY AND ANTI-SENSE DNA OF THE VASCULAR ENDOTHELIUM GROWTH FACTOR FOR THE TREATMENT OF ABNORMAL RETINA VASCULARIZATION |
JP2001501471A (ja) | 1996-09-24 | 2001-02-06 | メルク エンド カンパニー インコーポレーテッド | 血管新生の阻害のための遺伝子治療 |
AU5593398A (en) * | 1996-12-05 | 1998-06-29 | Alcon Laboratories, Inc. | The use of inhibitors of tgf-beta's functions to ameliorate ocular pathology |
US6413931B1 (en) * | 1999-05-10 | 2002-07-02 | The Texas A&M University System | Peptide inhibitor of fibrinogen blood clotting |
WO2001019386A2 (en) * | 1999-09-15 | 2001-03-22 | Dewoolfson Bruce H | Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
CA2385480A1 (en) * | 1999-09-24 | 2001-03-29 | Human Genome Sciences, Inc. | 32 human secreted proteins |
US7304137B2 (en) * | 2001-12-13 | 2007-12-04 | The Texas A & M University System | Nucleotide and amino acid sequences of asporins |
PL1638591T3 (pl) | 2003-05-29 | 2013-10-31 | Univ Manchester | Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych |
GB0423273D0 (en) | 2004-10-20 | 2004-11-24 | Univ Manchester | Treatment of cancer |
-
2004
- 2004-05-28 PL PL04735259T patent/PL1638591T3/pl unknown
- 2004-05-28 WO PCT/GB2004/002269 patent/WO2004105784A1/en active Search and Examination
- 2004-05-28 EP EP04735259A patent/EP1638591B1/en not_active Expired - Lifetime
- 2004-05-28 PT PT47352596T patent/PT1638591E/pt unknown
- 2004-05-28 JP JP2006530541A patent/JP4808623B2/ja not_active Expired - Fee Related
- 2004-05-28 ES ES04735259T patent/ES2408656T3/es not_active Expired - Lifetime
- 2004-05-28 DK DK04735259.6T patent/DK1638591T3/da active
- 2004-05-28 US US10/558,606 patent/US7358224B2/en not_active Expired - Fee Related
-
2008
- 2008-04-11 US US12/101,717 patent/US7910567B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2004105784A1 (en) | 2004-12-09 |
JP2007502855A (ja) | 2007-02-15 |
ES2408656T3 (es) | 2013-06-21 |
US20070021334A1 (en) | 2007-01-25 |
US7358224B2 (en) | 2008-04-15 |
US20090130192A1 (en) | 2009-05-21 |
EP1638591A1 (en) | 2006-03-29 |
PT1638591E (pt) | 2013-05-22 |
JP4808623B2 (ja) | 2011-11-02 |
DK1638591T3 (da) | 2013-06-03 |
EP1638591B1 (en) | 2013-03-13 |
US7910567B2 (en) | 2011-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2397500B (en) | Cartridge for the preparation of beverages | |
EP1587535A4 (en) | N-CYCLOHEXYLAMINOCARBONYL BENZENESULFONAMIDE DERIVATIVES | |
EP1909694A4 (en) | ELECTRICAL STIMULATION OF BLOOD VESSELS | |
IL173456A0 (en) | Process for the preparation of 4-amino-3-quinolinecarbonitriles | |
EP1795457A4 (en) | CONTAINER FOR MIXING A LIQUID INTO TWO PARTS OR SIMILAR | |
GB0303797D0 (en) | Blood assessment | |
ZA200407609B (en) | Use of vitamin d compounds | |
PL1838301T3 (pl) | Użycie resiniferatotoksyny (RTX) dla wytwarzania środka leczącego stany bólowe | |
GB2397496B (en) | Cartridge for the preparation of beverages | |
IL175743A0 (en) | Process for the preparation of thiazolopyrimidines | |
PL1638591T3 (pl) | Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych | |
GB2392441B (en) | Electrolytic activation of fluids | |
GB0305312D0 (en) | Tomography of curved surfaces | |
AU2003272198A1 (en) | Storage of blood | |
GB0318411D0 (en) | Vessel | |
HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
IL178907A0 (en) | Use of sulglicotide for the treatment of mucositis | |
IL161897A0 (en) | Process for the preparation of cephalexin | |
EP1616190A4 (en) | DIAGNOSIS OF CANCER AT AN ADVANCED STAGE | |
ZA200408616B (en) | The determination of medical aid options | |
HK1087111A1 (en) | Process for the preparation of nicotinaldehydes | |
IL158442A0 (en) | Blood vessels wall imaging catheter | |
HU0300255D0 (en) | Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine | |
TW573602U (en) | Avstract of the disclosrte | |
GB0218504D0 (en) | The determination of blood flow parameter |